The methylenetetrahydrofolate reductase gene polymorphism (C677T) is associated with increased cardiovascular mortality in Hungary

International Journal of Cardiology

Volumn 97, Issue 2, 2004, Pages 333-334

  Kalina, Ákos ^a,c   Czeizel, Andrew E ^b  

^a MAV Hospital   (Hungary)

^b FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

^c Táncsics M 20   (Hungary)

Author keywords

Coronary heart disease; Hyperhomocysteinaemia; Methylenetetrahydrofolate reductase; Myocardial infarction

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; HUMAN; HUNGARY; INFANT; ISCHEMIC HEART DISEASE; MALE; MORTALITY; NEWBORN; PRIORITY JOURNAL; THORAX PAIN;

AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; HUNGARY; INFANT, NEWBORN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 4644301651     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.08.021     Document Type: Article

References (11)

1. Frosst P., Blom H.J., Milos R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:1995;111-113
2. Klerk M., et al. The MTHFR Studies Collaboration Group MTHFR 677 C→T polymorphism and risk of coronary heart disease. JAMA. 288:2002;2023-2031
3. Kluijtmans L.A.J., Whitehead A.S. Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease. Eur. Heart J. 22:2001;294-299
4. Jee S.H., Beaty T.H., Suh I., Yoon Y.S., Appel L.J. The methylenetetrahydrofolate reductase gene is associated with increased cardiovascular risk in Japan, but not in other populations. Atherosclerosis. 153:2000;161-168
5. Morita H., Taguchi J., Kurihara H. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase as a risk factor for coronary artery disease. Circulation. 95:1997;2032-2036
6. Meisel C., Cascorbi I., Gerloff T., Stangl V., Laule M., Müller M.M., et al. Identification of six MTHFR genotypes resulting from common polymorphisms: impact on plasma homocysteine levels and development of coronary artery disease. Atherosclerosis. 154:2001;651-658
7. Brattström L., Wilcken D.E.L., Ohrvik J., Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinaemia but not to vascular disease: the results of a meta-analysis. Circulation. 98:1998;2520-2526
8. Rotenbacher D., Fischer G.H., Hoffmeister A., Hoffmann M.M., März W., Bode G., et al. Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, haemostatic, and lipid parameters. Atherosclerosis. 162:2002;193-200
9. Kim H.C., Hwang Y.K., Choi M.T., Shin Y.W., Hong Y.S. The methylenetetrahydrofolate reductase gene polymorphism in Koreans with coronary heart disease. Int. J. Cardiol. 78:2001;13-17
10. Márk L., Erdei F., Markizay J., Kondacs A., Katona A. Effect of treatment with folic acid and vitamin B6 on lipid and homocysteine concentrations in patients with coronary artery disease. Nutrition. 18:2002;428-429
11. Kluijtmans L.A.J., Whitehead A.S. Reduced frequency of the thermo labile methylenetetrahydrofolate reductase genotype in the elderly (letter). Atherosclerosis. 146:1999;395-397